Manager, Technical Accounting

Posted:
4/18/2024, 4:27:33 AM

Experience Level(s):
Expert or higher ⋅ Senior

Field(s):
Accounting

Roivant’s mission is to systematically reduce the time, cost, and risk of delivering new medicines to market by accelerating the development of promising drug candidates to improve the lives of patients and their families. Since its inception in 2014, Roivant has achieved the following critical milestones in support of its vision: built over 20 portfolio companies (Vants); 5 successful IPOs; 10 consecutive positive phase 3 trials; 6 FDA approvals; >10$B in global pharma partnerships and proceeds; expanding pipeline of assets across various modalities and therapeutic areas; successful commercial launch of VTAMA®, (tapinarof) cream, 1%, for the topical treatment of plaque psoriasis in adults.  Building upon this track record of establishing a robust pipeline through in-licensing and acquisition of novel assets and technology platforms, Roivant is currently building new capabilities in drug discovery and expanding upon existing development disciplines to become the leading tech-enabled pharmaceutical company.

To learn more about our story and company culture, please visit us at https://roivant.com/

Position Summary:

The Roivant Technical Accounting group operates like a national office, advising and supporting teams at Roivant and its subsidiaries (“Vants”) on complex accounting matters. The Manager, Technical Accounting is a highly visible position that plays a critical role in evaluating, recommending, and documenting accounting positions and policies for variety of transactions (e.g., acquisitions and divestitures, financial instruments, leases, share-based compensation, etc.). The Manager, Technical Accounting will also be a critical partner to the SEC reporting team, assisting with the preparation and management of SEC filings and coordinating with external auditors on key reporting and disclosure considerations. 

This is an exciting role on Roivant’s accounting team with high exposure to senior leadership and teams across the organization, reporting directly to the Associate Director, Technical Accounting. The ideal candidate for this role is team-oriented, has a strong desire for continued learning, and is comfortable working in a fast-paced role. 

The position is located out of our New York, NY office (hybrid/flexible work environment).  

Responsibilities 

Technical Accounting Research / Accounting Policies

  • Plan, direct, and coordinate technical accounting research for complex transactions, including financings, acquisitions, divestitures, consolidation assessments, equity method investments, share-based compensation, and other technical issues.
  • Prepare accounting memos and other documentation, and present conclusions to key stakeholders. Will require significant interaction and coordination with operational accounting staff, tax, and treasury teams.
  • Provide overall support to executive management and operational accounting teams by researching accounting questions, SEC reporting matters, and judgments, and by partnering with team members in other departments and at Vants.
  • Ideally, this candidate will have strong background in working with complex financial instruments, convertible debt, preferred stock financing, evaluating embedded derivatives, VIEs, etc.
  • Oversee the establishment and maintenance of accounting policies and procedures for all corporate entities to ensure operational efficiency and compliance with GAAP. This position will be a key US GAAP expert and work closely with the Associate Director, Technical Accounting.
  • For transactions requiring valuations, work with the external valuation firm to obtain and review for proper valuation. Understand different valuation methodologies utilized and document reasonableness.
  • Perform reviews of contracts and other documents as requested to ensure appropriate accounting and reporting treatment.
  • May perform/oversee highly complex projects or participate as a team member on projects at the highest level of technical complexity.
  • Support and coordinate with the external auditors on any technical accounting issues related to the financial statements audit.
  • Implement and maintain internal controls over financial reporting for SOX compliance with a focus on continuous improvement of the reporting process.
  • Assist with special or ad hoc projects as needed.
  • Keeping abreast of new accounting guidance and other rules and regulations, ensuring that implementation of new accounting standards is properly reflected in the relevant disclosures in the financial statements.
  • Assisting with training on US GAAP and SEC reporting matters across the organization

SEC Reporting

  • Assist the SEC reporting team with preparation and review of SEC filings (10-Q, 10-K, 8-K, etc.), including financial statements, footnotes, management’s discussion and analysis (MD&A), and other disclosures. 
  • Collaborate with internal teams and Vant management to gather information needed for disclosure.
  • Prepare footnote support schedules, tie-out binders, and disclosure checklists for SEC filings.
  • Partner with internal and Vant teams to identify changes in the business with potential financial reporting impact.
  • Coordinate with external auditors to ensure auditor alignment on disclosure and reporting considerations. 
  • Facilitate the preparation and review of presentations and information for the audit committee and other key stakeholders. 

Qualifications 

  • CPA, 5-8+ years’ experience in Accounting/Auditing, Big 4 advisory services experience preferred.
  • Leadership, strong results orientation, creativity, excellent analytical and financial skills, and outstanding communication skills.
  • Willingness and ability to create change and develop processes through indirect reporting relationships.
  • Ability to influence executive level management and lead, direct and develop staff.
  • Must be a team player and have clear and concise written, verbal and presentation skills. Must be able to communicate to both financial and non-financial management.
  • Problem solving with the ability to act independently to meet deadlines.
  • Excellent communication skills
  • Ability to influence and lead cross-functional project teams.
  • Highly motivated. Possesses time management skills and is comfortable in situations where work is fast paced.

Base salary for this role will be determined during the interview process and will vary based on multiple factors, including but not limited to prior experience, relevant expertise, current business needs, and market conditions.  The expected base salary for the role will generally be between $120,000 - $150,000 per year at the commencement of employment, but the final salary offered may be outside this range based on individual circumstances and business and market conditions. 

Base salary if hired is only part of the total compensation package, which, depending on the position, may also include other components such as discretionary bonuses, equity, and Company-sponsored benefit programs.

This position is at-will and Roivant reserves the right to modify base salary (as well as any other discretionary payment or compensation program) at any time, including for reasons related to individual performance and business and market conditions.

Roivant Sciences provides equal employment opportunities to all employees and applicants for employment and prohibits discrimination and harassment of any type without regard to race, color, religion, age, sex, national origin, disability status, genetics, protected veteran status, sexual orientation, gender identity or expression, or any other characteristic protected by federal, state or local laws.

We will not accept unsolicited resumes nor outreach from agencies. Please do not send agency resumes to our website or Roivant Sciences and affiliated employees. Thanks!

Roivant Sciences

Website: http://roivant.com/

Headquarter Location: New York, New York, United States

Employee Count: 501-1000

Year Founded: 2014

IPO Status: Public

Last Funding Type: Post-IPO Equity

Industries: Biopharma ⋅ Biotechnology ⋅ Health Care ⋅ Pharmaceutical ⋅ Product Research